{"id":1996,"date":"2020-09-04T12:19:21","date_gmt":"2020-09-04T10:19:21","guid":{"rendered":"http:\/\/girpaovhml.cluster027.hosting.ovh.net\/?page_id=1996"},"modified":"2024-06-12T12:00:13","modified_gmt":"2024-06-12T10:00:13","slug":"archives-actualites","status":"publish","type":"page","link":"https:\/\/www.girpa.fr\/index.php\/archives-actualites\/","title":{"rendered":"Archives actualit\u00e9s"},"content":{"rendered":"

\u00c9volutions  LMR<\/h2><\/div><\/div><\/div><\/div><\/div>

R\u00e9glementaire approbation\/suspension<\/h2><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div>

Juin 2024<\/h3>
<\/div><\/div><\/div>
<\/div>

Mai 2024<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2024\/1439 of 24 May 2024<\/strong><\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for fenazaquin, mepiquat and propamocarb in or on certain products<\/p>

Commission Regulation (EU) 2024\/1342 of 21 May 2024<\/strong> <\/a>amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for deltamethrin, metalaxyl, thiabendazole and trifloxystrobin in or on certain products<\/p>

Commission Regulation (EU) 2024\/1355 of 21 May 2024<\/strong><\/a> amending Annexes II, III and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for benzovindiflupyr, chlorantraniliprole, emamectin, quinclorac, spiromesifen, and triflumuron in or on certain products<\/p>

Commission Regulation (EU) 2024\/1314 of 15 May 2024<\/strong><\/a> amending Annex III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for dithianon in or on certain products<\/p>

Commission Regulation (EU) 2024\/1318 of 15 May 2024<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels prothioconazole in or on certain products<\/p>

Corrigendum to Commission Regulation (EU) 2024\/1342 of 21 May 2024<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for deltamethrin, metalaxyl, thiabendazole and trifloxystrobin in or on certain products (Official Journal of the European Union L, 2024\/1342, 22 May 2024)<\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div>

<\/div>

Avril 2024<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2024\/1078 of 15 April 2024<\/strong><\/a> amending Annexes II and IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, flonicamid, isofetamid, mefentrifluconazole, metazachlor, pyrimethanil and quartz sand in or on certain products<\/p>

<id=\"title\" class=\"title-bold\">Commission Regulation (EU) 2024\/1076 of 15 April 2024<\/strong><\/a> amending Annexes II and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for bispyribac, metosulam, oryzalin, oxasulfuron and triazoxide in or on certain products<\/p>

Commission Regulation (EU) 2024\/1077 of 15 April 2024<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for 2,4-DB, iodosulfuron-methyl, mesotrione and pyraflufen-ethyl in or on certain products<\/p><\/div><\/div>

<\/div>

Mars 2024<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2024\/891 of 22 March 2024<\/strong><\/a> amending Annexes II and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for bifenazate in or on certain products<\/p>

Commission Implementing Regulation (EU) 2024\/885 of 20 March 2024<\/strong><\/a> amending Implementing Regulation (EU) 2023\/2782 laying down the methods of sampling and analysis for the control of the levels of mycotoxins in food as regards the method of sampling for dried herbs, herbal infusions (dried product), teas (dried product) and powdered spices<\/p><\/div><\/div>

<\/div>

F\u00e9vrier 2024<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2024\/451 of 5 February 2024<\/strong><\/a> amending Annex III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for nicotine in or on certain products<\/p>

Corrigendum to Commission Regulation (EU) 2024\/344 of 22 January 2024<\/strong><\/a> amending and correcting Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for mandipropamid in or on certain products (Official Journal of the European Union L, 2024\/344, 23 January 2024)<\/p><\/div><\/div>

<\/div>

Janvier 2024<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2024\/345 of 22 January 2024<\/strong><\/a> amending Annexes II, III and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for desmedipham, etridiazole, flurtamone, profoxydim, difenacoum and potassium permanganate in or on certain products<\/p>

Commission Regulation (EU) 2024\/352 of 22 January 2024<\/strong><\/a> amending Annexes II and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for (Z)-13-hexadecen-11-yn-1-yl acetate, (Z,Z,Z,Z)-7,13,16,19-docosatetraen-1-yl isobutyrate, acrinathrin, azimsulfuron, famoxadone, prochloraz and sodium hypochlorite in or on certain products<\/p>

Commission Regulation (EU) 2024\/342 of 22 January 2024<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for cyflumetofen, oxathiapiprolin and pyraclostrobin in or on certain products<\/p>

Commission Regulation (EU) 2024\/376 of 24 January 2024<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for indoxacarb in or on certain products<\/p>

Commission Regulation (EU) 2024\/331 of 19 January 2024<\/strong><\/a> amending Annexes II and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for oxamyl in or on certain products<\/p>

Commission Regulation (EU) 2024\/341 of 22 January 2024<\/strong><\/a> amending Annexes II and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for diethofencarb, fenoxycarb, flutriafol and pencycuron in or on certain products<\/p>

Commission Regulation (EU) 2024\/398 of 29 January 2024<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for haloxyfop in or on certain products<\/p>

Commission Regulation (EU) 2024\/344 of 22 January 2024<\/strong><\/a> amending and correcting Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for mandipropamid in or on certain products<\/p>

Commission Regulation (EU) 2024\/347 of 22 January 2024<\/strong><\/a> amending Annexes II and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for fipronil in or on certain products<\/p><\/div><\/div>

<\/div>

d\u00e9cembre 2023<\/h3>
<\/div><\/div><\/div>
<\/div>

Novembre 2023<\/h3>
<\/div><\/div><\/div>
<\/div>

Octobre 2023<\/h3>
<\/div><\/div><\/div>
<\/div>

Septembre 2023<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2023\/1783 of 15 September 2023<\/strong><\/a> amending Annexes II and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for denatonium benzoate, diuron, etoxazole, methomyl and teflubenzuron in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2023\/1719 of 8 September 2023<\/strong><\/a> amending Annexes II and IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for isoxaben, metaldehyde, Metarhizium brunneum strain Ma 43, paclobutrazol and Straight Chain Lepidopteran Pheromones (SCLP) in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2023\/2382 of 29 September 2023<\/strong><\/a> amending Annexes II and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for carbetamide, carboxin and triflumuron in or on certain products<\/p>

Commission Regulation (EU) 2023\/1753 of 11 September 2023<\/strong><\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for pyriproxyfen in or on certain products (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Aout 2023<\/h3>
<\/div><\/div><\/div>
<\/div>

juillet 2023<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2023\/1536 of 25 July 2023<\/strong><\/a> amending Annex III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for nicotine in or on certain products.<\/p>

Commission Regulation (EU) 2023\/1510 of 20 July 2023<\/strong><\/a> amending Regulation (EU) 2023\/915 as regards maximum levels of cadmium in tiger nuts and certain cultivated fungi (Text with EEA relevance)<\/span><\/p><\/div><\/div>

<\/div>

juin 2023<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2023\/1068 of 1 June 2023<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for cyantraniliprole in or on certain products<\/p>

Commission Regulation (EU) 2023\/1069 of 1 June 2023<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for bixafen, cyprodinil, fenhexamid, fenpicoxamid, fenpyroximate, flutianil, isoxaflutole, mandipropamid, methoxyfenozide, and spinetoram in or on certain products<\/p><\/div><\/div>

<\/div>

Mai 2023<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2023\/1030 of 25 May 2023<\/strong><\/a> amending Annex IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards Bacillus amyloliquefaciens strain AH2, Bacillus amyloliquefaciens strain IT-45 and Purpureocillium lilacinum strain PL11<\/p>

Commission Regulation (EU) 2023\/1029 of 25 May 2023<\/strong><\/a> amending Annexes III and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for phosmet in or on certain products<\/p>

Commission Regulation (EU) 2023\/1042 of 26 May 2023<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for folpet in or on certain products<\/p>

Commission Regulation (EU) 2023\/1049 of 30 May 2023<\/strong><\/a> amending Annexes II and IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for fish oil, pendimethalin, sheep fat and spirotetramat in or on certain products<\/p><\/div><\/div>

<\/div>

Avril 2023<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2023\/915 of 25 April 2023<\/strong><\/a> on maximum levels for certain contaminants in food and repealing Regulation (EC) No 1881\/2006<\/span><\/p><\/div><\/div>

<\/div>

Mars 2023<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2023\/466 of 3 March 2023<\/strong><\/a> amending Annexes II, III and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for isoxaben, novaluron and tetraconazole in or on certain products<\/p>

Commission Regulation (EU) 2023\/679 of 23 March 2023<\/strong><\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for pyridaben, pyridate, pyriproxyfen and triclopyr in or on certain products<\/p>

Commission Regulation (EU) 2023\/710 of 30 March 2023<\/strong><\/a> amending Annexes II, III and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for bromopropylate, chloridazon, fenpropimorph, imazaquin and tralkoxydim in or on certain products<\/p><\/div><\/div>

<\/div>

F\u00e9vrier 2023<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2023\/377 of 15 February 2023<\/strong><\/a> amending Annexes II, III, IV and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for benzalkonium chloride (BAC), chlorpropham, didecyldimethylammonium chloride (DDAC), flutriafol, metazachlor, nicotine, profenofos, quizalofop-P, sodium aluminium silicate, thiabendazole and triadimenol in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2023\/334 of 2 February 2023<\/strong> <\/a>amending Annexes II and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for clothianidin and thiamethoxam in or on certain products (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Janvier 2023<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2023\/198 of 30 January 2023<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for abamectin in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2023\/128 of 18 January 2023<\/strong><\/a> amending Annexes II, III and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for benalaxyl, bromoxynil, chlorsulfuron, epoxiconazole and fenamiphos in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2023\/127 of 18 January 2023<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for acequinocyl in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2023\/147 of 20 January 2023<\/strong><\/a> amending Annexes II, III and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for cyromazine, topramezone and triflumizole in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2023\/173 of 26 January 2023<\/strong><\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for 1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide (PAM), cycloxydim, cyflumetofen, cyfluthrin, metobromuron and penthiopyrad in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2023\/129 of 18 January 2023<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, prosulfocarb, sedaxane and valifenalate in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2023\/163 of 18 January 2023<\/strong><\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for DDT and oxathiapiprolin in or on certain products (Text with EEA relevance)<\/p>

Corrigendum to Commission Regulation (EU) 2022\/1363 of 3 August 2022<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for 2,4-D, azoxystrobin, cyhalofop-butyl, cymoxanil, fenhexamid, flazasulfuron, florasulam, fluroxypyr, iprovalicarb and silthiofam in or on certain products (Official Journal of the European Union L 205 of 5 August 2022)<\/p><\/div><\/div>

<\/div>

D\u00e9cembre 2022<\/h3>
<\/div><\/div><\/div>

-<\/p><\/div><\/div>

<\/div>

Novembre 2022<\/h3>
<\/div><\/div><\/div>

-<\/p><\/div><\/div>

<\/div>

Octobre 2022<\/h3>
<\/div><\/div><\/div>

-<\/p><\/div><\/div>

<\/div>

Septembre 2022<\/h3>
<\/div><\/div><\/div>

-<\/p><\/div><\/div>

<\/div>

Aout 2022<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2022\/1435 of 26 August 2022<\/a><\/strong> amending Annexes II and IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for calcium carbonate, carbon dioxide, cyprodinil and potassium hydrogen carbonate in or on certain products<\/p>

Commission Regulation (EU) 2022\/1406 of 3 August 2022<\/strong><\/a> amending Annexes II, III and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for methoxyfenozide, propoxur, spinosad and thiram in or on certain products<\/p>

R\u00c8GLEMENT (UE) 2022\/1363 DE LA COMMISSION<\/span><\/span> du<\/span><\/span> 3 ao\u00fbt 2022<\/span><\/span><\/a><\/strong> modifiant  l\u2019annexe II du r\u00e8glement (CE) n<\/span>o<\/span> 396\/2005 du  Parlement europ\u00e9en et du Conseil en ce qui<\/span> concerne les limites maximales applicables aux  r\u00e9sidus de 2,4-D, d\u2019azoxystrobine, de cyhalofop-<\/span>butyl, de cymoxanil, de fenhexamide, de  flazasulfuron, de florasulam, de fluroxypyr, d\u2019iprovalicarbe<\/span> et de silthiofam pr\u00e9sents dans ou sur certains produits<\/span><\/span><\/p>

Commission Regulation (EU) 2022\/1346 of 1 August 2022<\/strong><\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for 1,4-dimethylnaphthalene, 8-hydroxyquinoline, pinoxaden and valifenalate in or on certain products (Text with EEA relevance<\/p><\/div><\/div>

<\/div>

Juillet 2022<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2022\/1343 of 29 July 2022<\/strong><\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for acequinocyl, chlorantraniliprole and emamectin in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2022\/1321 of 25 July 2022<\/strong><\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for fluoride ion, oxyfluorfen, pyroxsulam, quinmerac and sulfuryl fluoride in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2022\/1290 of 22 July 2022<\/strong><\/a> amending Annexes II, III and IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for ametoctradin, chlormequat, dodine, nicotine, profenofos and Spodoptera exigua multicapsid nucleopolyhedrovirus (SeMNPV) isolate BV-0004 in or on certain products<\/p>

Commission Regulation (EU) 2022\/1324 of 28 July 2022<\/strong><\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for benzovindiflupyr, boscalid, fenazaquin, fluazifop-P, flupyradifurone, fluxapyroxad, fosetyl-Al, isofetamid, metaflumizone, pyraclostrobin, spirotetramat, thiabendazole and tolclofos-methyl in or on certain products<\/p>

Commission Regulation (EU) 2022\/1264 of 20 July 2022<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for fludioxonil in or on certain products<\/p><\/div><\/div>

<\/div>

Juin 2022<\/h3>
<\/div><\/div><\/div>

-<\/p><\/div><\/div>

<\/div>

Mai 2022<\/h3>
<\/div><\/div><\/div>

-<\/p><\/div><\/div>

<\/div>

Avril 2022<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2022\/566 of 7 April 2022<\/a><\/strong> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for flutianil in or on certain products<\/p><\/div><\/div>

<\/div>

Mars 2022<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2022\/476 of 24 March 2022<\/a><\/strong> amending Annexes II, III and IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for acetic acid, azoxystrobin, benzovindiflupyr, cyantraniliprole, cyflufenamid, emamectin, flutolanil, lime sulphur, maltodextrin and proquinazid in or on certain products.<\/p><\/div><\/div>

<\/div>

F\u00e9vrier 2022<\/h3>
<\/div><\/div><\/div>

RAS<\/p><\/div><\/div>

<\/div>

Janvier 2022<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2022\/78 of 19 January 2022<\/strong><\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for dazomet, hexythiazox, metam and methylisothiocyanate in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2022\/93 of 20 January 2022<\/strong><\/a> amending Annexes II, III and IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for acrinathrin, fluvalinate, folpet, fosetyl, isofetamid, \u2018Pepino Mosaic Virus, EU strain, mild isolate Abp1\u2019, \u2018Pepino Mosaic Virus, CH2 strain, mild isolate Abp2\u2019, spinetoram and spirotetramat in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2022\/85 of 20 January 2022<\/strong><\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for flonicamid in or on certain products (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

D\u00e9cembre 2021<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2021\/2202 of 9 December 2021<\/a> amending Annexes II, III and IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for acequinocyl, Bacillus subtilis strain IAB\/BS03, emamectin, flutolanil and imazamox in or on certain products (Text with EEA relevance)<\/p>

 <\/p><\/div><\/div>

<\/div>

Octobre 2021<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2021\/1807 of 13 October 2021<\/a> amending Annexes II, III and IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for acibenzolar-S-methyl, aqueous extract from the germinated seeds of sweet Lupinus albus, azoxystrobin, clopyralid, cyflufenamid, fludioxonil, fluopyram, fosetyl, metazachlor, oxathiapiprolin, tebufenozide and thiabendazole in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2021\/1810 of 14 October 2021<\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards the maximum residue levels for cyprodinil in blueberries, cranberries, currants and gooseberries (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2021\/1804 of 12 October 2021<\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards the maximum residue level for bentazone in peas with pods (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2021\/1795 of 11 October 2021<\/a> correcting Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for terbuthylazine in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2021\/1864 of 22 October 2021<\/a> amending Annexes II, III and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for amisulbrom, flubendiamide, meptyldinocap, metaflumizone and propineb in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2021\/1881 of 26 October 2021<\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for imidacloprid in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2021\/1842 of 20 October 2021<\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for flupyradifurone and difluoroacetic acid in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2021\/1841 of 20 October 2021<\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for 6-benzyladenine and aminopyralid in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2021\/1884 of 27 October 2021<\/a> amending Annex III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for chlorantraniliprole in pulses (Text with EEA relevance)<\/p>

Rectificatif <\/span> au <\/span> r\u00e8glement <\/span> (UE) <\/span> 2020\/192 <\/span> de <\/span> la <\/span> Commission <\/span> du <\/span><\/span> 12 <\/span> f\u00e9vrier <\/span> 2020<\/span><\/span><\/a> modifiant <\/span> les <\/span>
annexes II et III du r\u00e8glement (CE) n<\/span>o <\/span> 396\/2005 du Parlement europ\u00e9en et du Conseil en ce qui <\/span>concerne les limites maximales applicables aux r\u00e9sidus de prochloraz pr\u00e9sents dans ou sur certains <\/span>
produits <\/span><\/span><\/p>

Rectificatif au r\u00e8glement (UE) 2021\/616 de la Commission du <\/span><\/span>13 avril 2021<\/span><\/span><\/a> modifiant les annexes II, <\/span>III et V du r\u00e8glement (CE) n<\/span>o <\/span> 396\/2005 du Parlement europ\u00e9en et du Conseil en ce qui concerne les <\/span>limites <\/span> maximales <\/span> applicables <\/span> aux <\/span> r\u00e9sidus <\/span> de <\/span> b\u00e9nalaxyl, <\/span> b\u00e9nalaxyl-M, <\/span> dichlob\u00e9nil, <\/span> fluopicolide, <\/span>proquinazid et pyridalyl pr\u00e9sents dans ou sur certains produits. <\/span><\/span><\/p>

Rectificatif au r\u00e8glement (UE) 2021\/618 de la Commission du <\/span><\/span> 15 avril 2021<\/span><\/span><\/a> modifiant les annexes II <\/span>et III du r\u00e8glement (CE) n<\/span>o <\/span> 396\/2005 du Parlement europ\u00e9en et du Conseil en ce qui concerne les <\/span>limites <\/span> maximales <\/span> applicables <\/span> aux <\/span> r\u00e9sidus <\/span> de <\/span> diclofop, <\/span> de <\/span> f luopyram, <\/span> d\u2019ipconazole <\/span> et <\/span> de t<\/span>erbuthylazine pr\u00e9sents dans ou sur certains produits<\/span><\/span><\/p><\/div><\/div>

<\/div>

Septembre 2021<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2021\/1531 of 17 September 2021<\/a> amending Annexes II, III and IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for aclonifen, acrinathrin, Bacillus pumilus QST 2808, ethirimol, penthiopyrad, picloram and Pseudomonas sp. strain DSMZ 13134 in or on certain products (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Juillet 2021<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2021\/1110 of 6 July 2021 amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for ametoctradin, bixafen, fenazaquin, spinetoram, tefluthrin and thiencarbazone-methyl in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2021\/1098 of 2 July 2021<\/a> amending Annexes II, III and IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for 24-epibrassinolide, Allium cepa L. bulb extract, cyflumetofen, fludioxonil, fluroxypyr, sodium 5-nitroguaiacolate, sodium o-nitrophenolate and sodium p-nitrophenolate in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2021\/1247 of 29 July 2021<\/a> amending Annex II to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for mandestrobin in grapes and strawberries (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Juin 2021<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2021\/976 of 4 June 2021<\/a> amending Annexes II, III and IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for cycloxydim, mepiquat, Metschnikowia fructicola strain NRRL Y-27328 and prohexadione in or on certain products (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Avril 2021<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2021\/590 of 12 April 2021<\/a> amending Annexes II and IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for aclonifen, boscalid, cow milk, etofenprox, ferric pyrophosphate, L-cysteine, lambda-cyhalothrin, maleic hydrazide, mefentrifluconazole, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate and triclopyr in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2021\/644 of 15 April 2021<\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for fluxapyroxad, hymexazol, metamitron, penflufen and spirotetramat in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2021\/616 of 13 April 2021<\/a> amending Annexes II, III and V to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for benalaxyl, benalaxyl-M, dichlobenil, fluopicolide, proquinazid and pyridalyl in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2021\/618 of 15 April 2021<\/a> amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for diclofop, fluopyram, ipconazole and terbuthylazine in or on certain products (Text with EEA relevance)<\/p>

Commission Regulation (EU) 2021\/663 of 22 April 2021<\/a> amending Annex III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for chlordecone in or on certain products (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/621 of 15 April<\/a> 2021 amending Regulation (EU) No 37\/2010 to classify the substance imidacloprid as regards its maximum residue limit in foodstuffs of animal origin (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

F\u00e9vrier 2021<\/h3>
<\/div><\/div><\/div>

R\u00c8GLEMENT (UE) 2021\/155 DE LA COMMISSION du 9 f\u00e9vrier 2021<\/a> modifiant les annexes II, III et V du r\u00e8glement (CE) no 396\/2005 du Parlement europ\u00e9en et du Conseil en ce qui concerne les limites maximales applicables aux r\u00e9sidus de t\u00e9trachlorure de carbone, de chlorothalonil, de chlorprophame, de dim\u00e9thoate, d\u2019\u00e9thoprophos, de f\u00e9namidone, de m\u00e9thiocarbe, d\u2019om\u00e9thoate, de propiconazole et de pym\u00e9trozine pr\u00e9sents dans ou sur certains produits.<\/p><\/div><\/div>

Typography is the art and technique<\/h2>\n

Typography is the art and technique of arranging type to make written language legible, readable and appealing when displayed. The arrangement of type involves selecting typefaces, point size, line length, line-spacing (leading), letter-spacing (tracking), and adjusting the space within letters pairs (kerning).<\/p><\/div><\/div>

Typography is the art and technique<\/h2>\n

Typography is the art and technique of arranging type to make written language legible, readable and appealing when displayed. The arrangement of type involves selecting typefaces, point size, line length, line-spacing (leading), letter-spacing (tracking), and adjusting the space within letters pairs (kerning).<\/p><\/div><\/div><\/div><\/div><\/div>

<\/div>

Juin 2024<\/h3>
<\/div><\/div><\/div>
<\/div>

Mai 2024<\/h3>
<\/div><\/div><\/div>

Commission Regulation (EU) 2024\/1487 of 29 May 2024<\/strong><\/a> defining data requirements for the approval of safeners and synergists and establishing a work programme for the gradual review of safeners and synergists on the market in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council<\/p><\/div><\/div>

<\/div>

Avril 2024<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2024\/1207 of 29 April 2024<\/strong><\/a> concerning the non-renewal of the approval of the active substance dimethomorph, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2024\/1217 of 29 April 2024<\/strong><\/a> concerning the non-renewal of the approval of the active substance mepanipyrim, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2024\/1280 of 30 April 2024<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the approval periods of the active substances dodemorph, fatty acids C8-C10 methyl esters, lauric acid, methyl octanoate, methyl decanoate, oleic acid and Trichoderma atroviride (formerly T. harzianum) strain IMI 206040<\/p>

Commission Implementing Regulation (EU) 2024\/1206 of 29 April 2024<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, dithianon, dodine, fluometuron, hexythiazox, isoxaben, lime sulphur, orange oil, prosulfuron, quinmerac, sintofen, sodium silver thiosulfate, tau-fluvalinate, tebufenozide, tembotrione and zinc phosphide<\/p><\/div><\/div>

<\/div>

Mars 2024<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2024\/835 of 12 March 2024<\/strong><\/a> renewing the approval of the active substance trinexapac, as trinexapac-ethyl, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2024\/839 of 8 March 2024<\/strong><\/a> renewing the approval of the low-risk active substance urea in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2024\/836 of 12 March 2024<\/strong><\/a> approving the basic substance magnesium hydroxide E528 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2024\/821 of 8 March 2024<\/strong><\/a> renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p><\/div><\/div>

<\/div>

F\u00e9vrier 2024<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2024\/425 of 2 February 2024<\/strong> <\/a>concerning the non-approval of the active substance asulam-sodium, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council<\/p><\/div><\/div>

<\/div>

Janvier 2024<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2024\/324 of 19 January 2024<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, bromuconazole, buprofezin, cyflufenamid, fluazinam, fluopyram, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metsulfuron-methyl, phosphane and pyraclostrobin<\/p><\/div><\/div>

<\/div>

D\u00e9cembre 2023<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2024\/20 of 12 December 2023<\/strong><\/a> concerning the non-renewal of the approval of the active substance S-metolachlor, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p><\/div><\/div>

<\/div>

Novembre 2023<\/h3>
<\/div><\/div><\/div>

R\u00c8GLEMENT D\u2019EX\u00c9CUTION (UE) 2023\/2660 DE LA COMMISSION<\/strong><\/a>
du 28 novembre 2023<\/strong>
renouvelant l\u2019approbation de la substance active \u00abglyphosate\u00bb conform\u00e9ment au r\u00e8glement (CE) no 1107\/2009 du Parlement europ\u00e9en et du Conseil, et modifiant le r\u00e8glement d\u2019ex\u00e9cution (UE) no 540\/2011 de la Commission (Texte pr\u00e9sentant de l\u2019int\u00e9r\u00eat pour l\u2019EEE)<\/p>

Commission Implementing Regulation (EU) 2023\/2513 of 16 November 2023<\/a><\/strong> concerning the non-renewal of the approval of the active substance triflusulfuron-methyl, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/2456 of 7 November 2023<\/strong><\/a> concerning the non-renewal of the approval of the active substance clofentezine, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/2657 of 6 November 2023<\/strong><\/a> concerning the non-renewal of the approval of the active substance benthiavalicarb, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/2591 of 21 November 2023<\/strong><\/a> renewing the approval of the active substance ethephon in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/2455 of 7 November 2023<\/strong><\/a> concerning the non-renewal of the approval of the active substance metiram, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/2589 of 21 November 2023<\/strong><\/a> renewing the approval of the active substance aluminium ammonium sulfate in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/2592 of 21 November 2023<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval periods of the active substances 1-naphthylacetamide, 1-naphthylacetic acid, 2-phenylphenol (incl. its salts such as sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fluazifop P, lenacil, napropamide, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, spiroxamine, sulphur, tetraconazole and tri-allate<\/p><\/div><\/div>

<\/div>

Octobre 2023<\/h3>
<\/div><\/div><\/div>
<\/div>

Septembre 2023<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2023\/1757 of 11 September 2023<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval periods of the active substances bensulfuron, chlormequat, chlorotoluron, clomazone, daminozide, deltamethrin, eugenol, fludioxonil, flufenacet, flumetralin, fosthiazate, geraniol, MCPA, MCPB, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulfuryl fluoride, tebufenpyrad, thymol, and tritosulfuron (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2023\/1784 of 15 September 2023<\/strong><\/a> amending Implementing Regulation (EU) No 686\/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of etoxazole whose approval expires on 31 January 2028 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2022\/1468 of 5 September 2022<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the conditions of approval of the active substance penflufen and repealing Implementing Regulation (EU) 2018\/185 (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Aout 2023<\/h3>
<\/div><\/div><\/div>
<\/div>

Juillet 2023<\/h3>
<\/div><\/div><\/div>
<\/div><\/div>

Commission Implementing Regulation (EU) 2023\/1488 of 6 July 2023<\/strong><\/a> renewing the approval of the low-risk active substance quartz sand in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/1436 of 10 July 2023<\/strong><\/a> concerning the non-renewal of the approval of the active substance dimoxystrobin, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011 and Commission Implementing Regulation (EU) 2015\/408<\/p>

Commission Implementing Regulation (EU) 2023\/1446 of 12 July 2023<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval periods of the active substances 2,5-dichlorobenzoic acid methylester, acetic acid, aluminium ammonium sulphate, aluminium phosphide, aluminium silicate, calcium carbide, cymoxanil, dodemorph, ethylene, extract from tea tree, fat distillation residues, fatty acids C7-C20, flonicamid (IKI-220), gibberellic acid, gibberellins, halosulfuron-methyl, hydrolysed proteins, iron sulphate, magnesium phosphide, maltodextrin, metamitron, plant oils\/clove oil, plant oils\/rape seed oil, plant oils\/spear mint oil, pyrethrins, sulcotrione, tebuconazole and urea<\/p>

Commission Implementing Regulation (EU) 2023\/1447 of 12 July 2023<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the approval periods of the active substances Bacillus pumilus QST 2808 and penflufen<\/p><\/div><\/div>

<\/div>

Juin 2023<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2023\/1078 of 2 June 2023<\/strong><\/a> approving ozone generated from oxygen as an active substance for use in biocidal products of product-types 2, 4, 5 and 11 in accordance with Regulation (EU) No 528\/2012 of the European Parliament and of the Council<\/p><\/div><\/div>

<\/div>

Mai 2023<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2023\/1021 of 24 May 2023<\/strong><\/a> renewing the approval of the active substance Bacillus thuringiensis subsp. kurstaki PB 54 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/918 of 4 May 2023<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval periods of the active substances aclonifen, ametoctradin, beflubutamid, benthiavalicarb, boscalid, captan, clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, dimethomorph, ethephon, fenazaquin, fluopicolide, fluoxastrobin, flurochloridone, folpet, formetanate, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, indolylbutyric acid, mandipropamid, metalaxyl, metaldehyde, metam, metazachlor, metribuzin, milbemectin, paclobutrazol, penoxsulam, phenmedipham, pirimiphos-methyl, propamocarb, proquinazid, prothioconazole, S-metolachlor, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237<\/p>

Commission Implementing Regulation (EU) 2023\/1001 of 23 May 2023<\/strong><\/a> renewing the approval of the active substance Bacillus amyloliquefaciens strain QST 713 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/999 of 23 May 2023<\/strong><\/a> renewing the approval of the active substance Bacillus thuringiensis subsp. israelensis strain AM65-52 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/1000 of 23 May 2023<\/strong><\/a> renewing the approval of the active substance Bacillus thuringiensis subsp. aizawai GC-91 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/998 of 23 May 2023<\/strong><\/a> renewing the approval of the active substance Bacillus thuringiensis subsp. kurstaki ABTS-351 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/1004 of 23 May 2023<\/strong><\/a> renewing the approval of the active substance Bacillus thuringiensis subsp. kurstaki SA-11 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/1005 of 23 May 2023<\/strong><\/a> renewing the approval of the active substance Bacillus thuringiensis subsp. Kurstaki SA-12 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/1002 of 23 May 2023 renewing the approval of the active substance Bacillus thuringiensis subsp. aizawai strain ABTS-1857 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/1002 of 23 May 2023<\/strong><\/a> renewing the approval of the active substance Bacillus thuringiensis subsp. aizawai strain ABTS-1857 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/1003 of 23 May 2023<\/strong><\/a> renewing the approval of the active substance Bacillus thuringiensis subsp. kurstaki EG2348 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/939 of 10 May 2023<\/strong><\/a> withdrawing the approval of the active substance ipconazole in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, amending Commission Implementing Regulation (EU) No 540\/2011 and repealing Commission Implementing Regulation (EU) No 571\/2014<\/p>

Commission Implementing Regulation (EU) 2023\/932 of 8 May 2023<\/strong> <\/a>amending Implementing Regulation (EU) No 540\/2011 as regards the approval period of the active substance pyridalyl<\/p>

Commission Regulation (EU) 2023\/915 of 25 April 2023<\/strong><\/a> on maximum levels for certain contaminants in food and repealing Regulation (EC) No 1881\/2006 (Text with EEA relevance)<\/span><\/p><\/div><\/div>

<\/div>

Avril 2023<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2023\/741 of 5 April 2023<\/strong><\/a> concerning the non-renewal of the approval of the active substance oxamyl, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011
Commission Implementing Regulation (EU) 2023\/741 of 5 April 2023<\/strong><\/a> concerning the non-renewal of the approval of the active substance oxamyl, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/731 of 3 April 2023<\/strong><\/a> concerning a coordinated multiannual control programme of the Union for 2024, 2025 and 2026 to ensure compliance with maximum residue levels of pesticides and to assess the consumer exposure to pesticide residues in and on food of plant and animal origin and repealing Implementing Regulation (EU) 2022\/741<\/p><\/div><\/div>

<\/div>

Mars 2023<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2023\/574 of 13 March 2023<\/strong><\/a> setting out detailed rules for the identification of unacceptable co-formulants in plant protection products in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council<\/p>

Commission Implementing Regulation (EU) 2023\/515 of 8 March 2023<\/strong><\/a> renewing the approval of the active substance abamectin in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2023\/689 of 20 March 2023<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval periods of the active substances Bacillus subtilis (Cohn 1872) strain QST 713, Bacillus thuringiensis subsp. Aizawai strains ABTS-1857 and GC-91, Bacillus thuringiensis subsp. Israeliensis (serotype H-14) strain AM65-52, Bacillus thuringiensis subsp. Kurstaki strains ABTS 351, PB 54, SA 11, SA12 and EG 2348, Beauveria bassiana strains ATCC 74040 and GHA, clodinafop, Cydia pomonella Granulovirus (CpGV), cyprodinil, dichlorprop-P, fenpyroximate, fosetyl, malathion, mepanipyrim, metconazole, metrafenone, pirimicarb, pyridaben, pyrimethanil, rimsulfuron, spinosad, Trichoderma asperellum (formerly T. harzianum) strains ICC012, T25 and TV1, Trichoderma atroviride (formerly T. harzianum) strain T11, Trichoderma gamsii (formerly T. viride) strain ICC080, Trichoderma harzianum strains T-22 and ITEM 908, triclopyr, trinexapac, triticonazole and ziram<\/p>

Commission Implementing Regulation (EU) 2023\/543 of 9 March 2023<\/strong><\/a> amending Implementing Regulation (EU) No 686\/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of active substances whose approval expires between 31 January 2029 and 1 October 2035<\/p><\/div><\/div>

<\/div>

F\u00e9vrier 2023<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2023\/216 of 1 February 2023<\/strong><\/a> approving the low-risk active substance Trichoderma atroviride AGR2 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Janvier 2023<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2023\/199 of 30 January 2023<\/strong><\/a> approving the low-risk active substance Trichoderma atroviride AT10 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2023\/223 of 27 January 2023<\/strong> <\/a>renewing the approval of the active substance Pseudomonas chlororaphis strain MA 342 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2023\/200 of 30 January 2023<\/strong><\/a> concerning the non-approval of lemon essential oil (Citrus limon essential oil) as a basic substance in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2023\/149 of 20 January 2023<\/strong><\/a> concerning the non-renewal of the approval of the active substance benfluralin, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2023\/114 of 16 January 2023<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, buprofezin, cyflufenamid, fluazinam, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metiram, metsulfuron-methyl, phosphane and pyraclostrobin (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2023\/121 of 17 January 2023<\/strong><\/a> amending and correcting Implementing Regulation (EU) 2021\/1165 authorising certain products and substances for use in organic production and establishing their lists<\/p>

Commission Implementing Regulation (EU) 2023\/116 of 16 January 2023<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval period of the active substance oxamyl (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2023\/115 of 16 January 2023<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval period of the active substance dimoxystrobin (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

D\u00e9cembre 2022<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2022\/2364 of 2 December 2022<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval period of the active substance glyphosate<\/p><\/div><\/div>

<\/div>

Novembre 2022<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2022\/2314 of 25 November 2022<\/strong><\/a> renewing the approval of the active substance Pythium oligandrum strain M1 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2022\/2315 of 25 November 2022<\/strong><\/a> renewing the approval of the low-risk active substance heptamaloxyloglucan in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2022\/2305 of 24 November 2022<\/strong><\/a> renewing the approval of the low-risk active substance Fish oil in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011<\/p><\/div><\/div>

<\/div>

Octobre 2022<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2022\/1993 of 20 October 2022<\/strong><\/a> approving Chrysanthemum cinerariaefolium extract from open and mature flowers of Tanacetum cinerariifolium obtained with supercritical carbon dioxide as an active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528\/2012 of the European Parliament and of the Council.<\/p>

Commission Implementing Regulation (EU) 2022\/1992 of 20 October 2022<\/strong><\/a> approving Chrysanthemum cinerariaefolium extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents as an active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528\/2012 of the European Parliament and of the Council<\/p><\/div><\/div>

<\/div>

Septembre 2022<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2022\/1480 of 7 September 2022<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuron<\/p>

Commission Implementing Regulation (EU) 2022\/1474 of 6 September 2022<\/a><\/strong> renewing the approval of the low-risk active substance sheep fat in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2022\/1468 of 5 September 2022<\/strong><\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the conditions of approval of the active substance penflufen and repealing Implementing Regulation (EU) 2018\/185<\/p><\/div><\/div>

<\/div>

Aout 2022<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2022\/1444 of 31 August 2022<\/strong><\/a> concerning the non-approval of black soap E470a as a basic substance in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market<\/p>

Commission Implementing Regulation (EU) 2022\/1443 of 31 August 2022<\/strong><\/a> concerning the non-approval of calcium propionate as a basic substance in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market<\/p>

Commission Regulation (EU) 2022\/1438 of 31 August 2022<\/strong><\/a> amending Annex II to Regulation (EC) No 1107\/2009 of the European Parliament and of the Council as regards specific criteria for the approval of active substances that are micro-organisms<\/p>

Commission Recommendation (EU) 2022\/1431 of 24 August 2022<\/strong><\/a> on the monitoring of perfluoroalkyl substances in food<\/p>

Commission Implementing Regulation (EU) 2022\/1428<\/strong> of 24 August 2022 laying down methods of sampling and analysis for the control of perfluoroalkyl substances in certain foodstuffs<\/p>

R\u00c8GLEMENT (UE) 2022\/1396 DE LA  COMMISSION<\/span><\/span> du<\/span><\/span> 11 ao\u00fbt 2022<\/span><\/span><\/strong><\/a> modifiant<\/span> l\u2019annexe<\/span> du<\/span> r\u00e8glement<\/span> (UE)<\/span> n<\/span>o<\/span> 231\/2012 <\/span>\u00e9tablissant<\/span> les<\/span> sp\u00e9cifications<\/span> des<\/span> additifs<\/span> alimentaires \u00e9num\u00e9r\u00e9s aux annexes II et III du  r\u00e8glement (CE) n<\/span>o<\/span> 1333\/2008 du  Parlement europ\u00e9en <\/span>et du Conseil, en ce qui  concerne la pr\u00e9sence d\u2019oxyde d\u2019\u00e9thyl\u00e8ne dans  les additifs alimentaires<\/span><\/span><\/p><\/div><\/div>

<\/div>

Juillet 2022<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2022\/1251 of 19 July 2022<\/strong><\/a> renewing the approval of the active substances Straight Chain Lepidopteran Pheromones (acetates) as low-risk active substances, and Straight Chain Lepidopteran Pheromones (aldehydes and alcohols) in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011<\/p><\/div><\/div>

<\/div>

Juin 2022<\/h3>
<\/div><\/div><\/div>

-<\/p><\/div><\/div>

<\/div>

Mai 2022<\/h3>
<\/div><\/div><\/div>

<\/span>R\u00c8GLEMENT D\u2019EX\u00c9CUTION (UE) 2022\/801 DE LA COMMISSION<\/span><\/span> du<\/span><\/span> 20 mai 2022<\/span><\/span><\/strong><\/a> modifiant le r\u00e8glement d\u2019ex\u00e9cution (UE) n<\/span>o <\/span>540\/2011 pour mettre \u00e0 jour la liste des  substances<\/span> actives approuv\u00e9es ou r\u00e9put\u00e9es  approuv\u00e9es en vertu du r\u00e8glement (CE) n<\/span>o <\/span>1107\/2009 du Parlement <\/span>europ\u00e9en et du Conseil<\/span><\/span><\/p>

Commission Implementing Regulation (EU) 2022\/782 of 18 May 2022<\/strong><\/a> withdrawing the approval of the active substance isopyrazam in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, amending Commission Implementing Regulation (EU) No 540\/2011 and repealing Implementing Regulation (EU) No 1037\/2012<\/p>

<\/span>R\u00c8GLEMENT D\u2019EX\u00c9CUTION (UE) 2022\/751 DE LA COMMISSION<\/span><\/span> du<\/span><\/span> 16 mai 2022<\/span><\/span><\/strong><\/a> concernant la non-approbation de la substance active \u00abchloropicrine\u00bb, conform\u00e9ment au r\u00e8glement<\/span> (CE) n<\/span>o<\/span> 1107\/2009 du Parlement europ\u00e9en et du Conseil concernant la mise sur le march\u00e9 des <\/span>produits phytopharmaceutiques<\/span><\/span><\/p>

R\u00c8GLEMENT D\u2019EX\u00c9CUTION (UE) 2022\/740 DE LA COMMISSION<\/span><\/span> du<\/span><\/span> 13 mai 2022<\/span><\/span><\/strong><\/a> concernant la non-approbation de la  substance active \u00ab1,3-dichloroprop\u00e8ne\u00bb,  conform\u00e9ment au<\/span> r\u00e8glement (CE) n<\/span>o <\/span>1107\/2009 du Parlement europ\u00e9en et du  Conseil concernant la mise sur le march\u00e9 <\/span>des produits phytopharmaceutiques<\/span><\/span><\/p>

R\u00c8GLEMENT D\u2019EX\u00c9CUTION (UE) 2022\/698 DE LA COMMISSION <\/span><\/span>du<\/span><\/span> 3 mai 2022<\/span><\/span><\/a><\/strong> renouvelant l\u2019approbation de la substance active \u00abbif\u00e9nazate\u00bb conform\u00e9ment au r\u00e8glement (CE)<\/span> n<\/span>o<\/span> 1107\/2009 du Parlement europ\u00e9en et du Conseil concernant la mise sur le march\u00e9 des produits<\/span> phytopharmaceutiques, et modifiant l\u2019annexe du r\u00e8glement d\u2019ex\u00e9cution (UE) n<\/span>o<\/span> 540\/2011 de la <\/span>Commission<\/span><\/span><\/p><\/div><\/div>

<\/div>

Avril 2022<\/h3>
<\/div><\/div><\/div>

RAS<\/p><\/div><\/div>

<\/div>

Mars 2022<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2022\/501 of 25 March 2022<\/a><\/strong> approving the active substance Beauveria bassiana strain 203 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011.<\/p>

Commission Implementing Regulation (EU) 2022\/496 of 28 March 2022<\/a><\/strong> approving the low-risk active substance Spodoptera exigua multicapsid nucleopolyhedrovirus (SeMNPV), isolate BV-0004 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540\/2011.<\/p>

Commission Implementing Regulation (EU) 2022\/456 of 21 March 2022<\/a><\/strong> approving the basic substance chitosan in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Implementing Regulation (EU) No 540\/2011.<\/p>

Commission Implementing Regulation (EU) 2022\/437 of 16 March 2022<\/a> <\/strong>renewing the approval of the active substance carbon dioxide in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011.<\/p>

Commission Implementing Regulation (EU) 2022\/383 of 4 March 2022<\/a> <\/strong>renewing the approval of the low-risk active substance Metarhizium brunneum strain Ma 43 (formerly Metarhizium anisopliae var. anisopliae strain BIPESCO 5\/F52) in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011<\/p><\/div><\/div>

<\/div>

F\u00e9vrier 2022<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2022\/159 of 4 February 2022<\/a><\/strong> approving the low-risk active substance Bacillus amyloliquefaciens strain IT-45 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Janvier 2022<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2022\/4 of 4 January 2022<\/a><\/strong> approving the active substance Purpureocillium lilacinum strain PL11 as a low-risk substance in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2022\/19 of 7 January 2022<\/a><\/strong> renewing the approval of the active substance Purpureocillium lilacinum strain 251 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011<\/p>

Commission Implementing Regulation (EU) 2022\/43 of 13 January 2022<\/a><\/strong> renewing the approval of the active substance flumioxazin in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annexes to Commission Implementing Regulation (EU) No 540\/2011 and to Implementing Regulation (EU) 2015\/408 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2022\/94 of 24 January 2022<\/a><\/strong> concerning the non-renewal of the approval of the active substance phosmet, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

D\u00e9cembre 2021<\/h3>
<\/div><\/div><\/div>

Regulation (EU) 2021\/2115 of the European Parliament and of the Council of 2 December 2021<\/a> establishing rules on support for strategic plans to be drawn up by Member States under the common agricultural policy (CAP Strategic Plans) and financed by the European Agricultural Guarantee Fund (EAGF) and by the European Agricultural Fund for Rural Development (EAFRD) and repealing Regulations (EU) No 1305\/2013 and (EU) No 1307\/2013<\/em><\/strong><\/p>

Commission Regulation (EU) 2021\/2010 of 17 November 2021 amending Regulation (EC) No 1185\/2009<\/a> of the European Parliament and of the Council concerning statistics on pesticides, as regards the list of active substances (Text with EEA relevance)<\/em><\/strong><\/p>

Commission Regulation (EU) 2021\/2202 of 9 December 2021<\/a> amending Annexes II, III and IV to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for acequinocyl, Bacillus subtilis strain IAB\/BS03, emamectin, flutolanil and imazamox in or on certain products (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Novembre 2021<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2021\/2049 of 24 November 2021 renewing the approval of the active substance cypermethrin<\/a> as a candidate for substitution in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/2081 of 26 November 2021 concerning the non-renewal of approval of the active substance indoxacarb<\/a>, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/2068 of 25 November 2021 amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin<\/a> (Text with EEA relevance)<\/p>

Consolidated text: Commission Implementing Regulation (EU) 2019\/1793 of 22 October 2019 on the temporary increase of official controls and emergency measures governing the entry into the Union of certain goods from certain third countries implementing Regulations (EU) 2017\/625 and (EC) No 178\/2002 of the European Parliament and of the Council and repealing Commission Regulations (EC) No 669\/2009, (EU) No 884\/2014, (EU) 2015\/175, (EU) 2017\/186 and (EU) 2018\/1660<\/em><\/strong><\/a><\/p>

Commission Implementing Regulation (EU) 2021\/2049 of 24 November 2021<\/a> renewing the approval of the active substance cypermethrin as a candidate for substitution in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/2081 of 26 November 2021<\/a> concerning the non-renewal of approval of the active substance indoxacarb, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/2068 of 25 November 2021<\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Septembre 2021<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2021\/1452 of 3 September 2021<\/a> renewing the approval of the active substance potassium hydrogen carbonate as a low-risk substance in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/1455 of 6 September 2021<\/a> approving the low-risk active substance Bacillus amyloliquefaciens strain AH2 in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/1448 of 3 September 2021<\/a> renewing the approval of the low-risk active substance calcium carbonate in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council Commission Implementing Regulation (EU) 2021\/1451 of 3 September 2021 concerning the non-approval of dimethyl sulphide as a basic substance in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/1449 of 3 September 2021<\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/1450 of 3 September 2021<\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the approval periods of the active substances acrinathrin and prochloraz (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Aout 2021<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2021\/1379 of 19 August 2021<\/a> concerning the non-renewal of approval of the active substance famoxadone, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

 <\/p><\/div><\/div>

<\/div>

Juillet 2021<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2021\/1191 of 19 July 2021<\/a> renewing the approval of the active substance clopyralid in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/1177 of 16 July 2021<\/a> amending Implementing Regulation (EU) 2015\/408 as regards the deletion of propoxycarbazone from the list of active substances to be considered as candidates for substitution (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Mai 2021<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2021\/843 of 26 May 2021<\/a> renewing the approval of the active substance cyazofamid, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/795 of 17 May 2021<\/a> withdrawing the approval of the active substance alpha-cypermethrin in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/824 of 21 May 2021<\/a> amending Implementing Regulations (EU) No 540\/2011 and (EU) No 820\/2011 as regards the conditions of approval of the active substance terbuthylazine (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/745 of 6 May 2021<\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval periods of the active substances aluminium ammonium sulphate, aluminium silicate, beflubutamid, benthiavalicarb, bifenazate, boscalid, calcium carbonate, captan, carbon dioxide, cymoxanil, dimethomorph, ethephon, extract from tea tree, famoxadone, fat distilation residues, fatty acids C7 to C20, flumioxazine, fluoxastrobin, flurochloridone, folpet, formetanate, gibberellic acid, gibberellins, heptamaloxyloglucan, hydrolysed proteins, iron sulphate, metazachlor, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, plant oils\/rape seed oil, potassium hydrogen carbonate, propamocarb, prothioconazole, quartz sand, fish oil, repellents by smell of animal or plant origin\/ sheep fat, S-metolachlor, Straight Chain Lepidopteran Pheromones, tebuconazole and urea (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/726 of 4 May 2021<\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the approval periods of the active substances Adoxophyes orana granulovirus and flutriafol (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Avril 2021<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2021\/567 of 6 April 2021<\/a> approving the low-risk active substance aqueous extract from the germinated seeds of sweet Lupinus albus in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Mars 2021<\/h3>
<\/div><\/div><\/div>

Commission Implementing Regulation (EU) 2021\/427 of 10 March 2021<\/a> approving the active substance 24-epibrassinolide as a low-risk substance in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540\/2011 (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/459 of 16 March 2021<\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the conditions of approval of the active substance fenpyrazamine (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/574 of 30 March 2021<\/a> amending Implementing Regulations (EU) 2017\/375 and (EU) No 540\/2011 as regards the conditions of approval of the active substance prosulfuron (Text with EEA relevance)<\/p>

Commission Implementing Regulation (EU) 2021\/566 of 30 March 2021<\/a> amending Implementing Regulation (EU) No 540\/2011 as regards the extension of the approval periods of the active substances abamectin, Bacillus subtilis (Cohn 1872) strain QST 713, Bacillus thuringiensis subsp. Aizawai strains ABTS-1857 and GC-91, Bacillus thuringiensis subsp. Israeliensis (serotype H-14) strain AM65-52, Bacillus thuringiensis subsp. Kurstaki strains ABTS 351, PB 54, SA 11, SA12 and EG 2348, Beauveria bassiana strains ATCC 74040 and GHA, clodinafop, clopyralid, Cydia pomonella Granulovirus (CpGV), cyprodinil, dichlorprop-P, fenpyroximate, fosetyl, mepanipyrim, Metarhizium anisopliae (var. anisopliae) strain BIPESCO 5\/F52, metconazole, metrafenone, pirimicarb, Pseudomonas chlororaphis strain MA342, pyrimethanil, Pythium oligandrum M1, rimsulfuron, spinosad, Streptomyces K61 (formerly \u2018S. griseoviridis\u2019), Trichoderma asperellum (formerly \u2018T. harzianum\u2019) strains ICC012, T25 and TV1, Trichoderma atroviride (formerly \u2018T. harzianum\u2019) strain T11, Trichoderma gamsii (formerly \u2018T. viride\u2019) strain ICC080, Trichoderma harzianum strains T-22 and ITEM 908, triclopyr, trinexapac, triticonazole and ziram (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

Janvier 2021<\/h3>
<\/div><\/div><\/div>

R\u00e8glement d\u2019ex\u00e9cution (UE) 2020\/2007 de la Commission du 8 d\u00e9cembre 2020<\/a> modifiant le r\u00e8glement d\u2019ex\u00e9cution (UE) no 540\/2011 en ce qui concerne la prolongation de la p\u00e9riode d\u2019approbation des substances actives \u00ab1-d\u00e9canol\u00bb, \u00ab1,4-dim\u00e9thylnaphthal\u00e8ne\u00bb, \u00ab6-benzylad\u00e9nine\u00bb, \u00abac\u00e9quinocyl\u00bb et 50 autres substances actives<\/strong><\/p><\/div><\/div>

R\u00e8glement d\u2019ex\u00e9cution (UE) 2020\/2101 de la Commission du 15 d\u00e9cembre 2020<\/a> portant renouvellement de l\u2019approbation de la substance active \u00abkieselgur (terre \u00e0 diatom\u00e9es)\u00bb<\/strong> conform\u00e9ment au r\u00e8glement (CE) no 1107\/2009 du Parlement europ\u00e9en et du Conseil concernant la mise sur le march\u00e9 des produits phytopharmaceutiques, et modifiant l\u2019annexe du r\u00e8glement d\u2019ex\u00e9cution (UE) no 540\/2011 de la Commission (Texte pr\u00e9sentant de l\u2019int\u00e9r\u00eat pour l\u2019EEE) <\/p><\/div><\/div>

R\u00e8glement d\u2019ex\u00e9cution (UE) 2020\/2105 de la Commission du 15 d\u00e9cembre 2020<\/a> renouvelant l\u2019approbation de la substance active \u00ab\u00e9toxazole\u00bb<\/strong> en tant que substance dont on envisage la substitution, conform\u00e9ment au r\u00e8glement (CE) no 1107\/2009 du Parlement europ\u00e9en et du Conseil concernant la mise sur le march\u00e9 des produits phytopharmaceutiques, et modifiant l\u2019annexe du r\u00e8glement d\u2019ex\u00e9cution (UE) no 540\/2011 de la Commission (Texte pr\u00e9sentant de l\u2019int\u00e9r\u00eat pour l\u2019EEE)<\/p><\/div><\/div>

R\u00e8glement d\u2019ex\u00e9cution (UE) 2020\/2087 de la Commission du 14 d\u00e9cembre 2020<\/a> portant sur le non-renouvellement de l\u2019approbation de la substance active \u00abmancoz\u00e8be\u00bb<\/strong>, conform\u00e9ment au r\u00e8glement (CE) no 1107\/2009 du Parlement europ\u00e9en et du Conseil concernant la mise sur le march\u00e9 des produits phytopharmaceutiques, et modifiant l\u2019annexe du r\u00e8glement d\u2019ex\u00e9cution (UE) no 540\/2011 de la Commission (Texte pr\u00e9sentant de l\u2019int\u00e9r\u00eat pour l\u2019EEE) <\/p><\/div><\/div>

R\u00e8glement d\u2019ex\u00e9cution (UE) 2020\/1643 de la Commission du 5 novembre 2020<\/a> modifiant le r\u00e8glement d\u2019ex\u00e9cution (UE) no 540\/2011 en ce qui concerne la p\u00e9riode d\u2019approbation des substances actives \u00abphosphure de calcium\u00bb, \u00abbenzoate de d\u00e9natonium\u00bb, \u00abhaloxyfop-P\u00bb, \u00abimidacloprid\u00bb, \u00abpencycuron\u00bb et \u00abz\u00e9ta-cyperm\u00e9thrine\u00bb<\/strong> (Texte pr\u00e9sentant de l\u2019int\u00e9r\u00eat pour l\u2019EEE)<\/p>

Commission Implementing Regulation (EU) 2021\/80 of 27 January 2021<\/a> concerning the non-approval of carbon dioxide as a basic substance in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (Text with EEA relevance)<\/p><\/div><\/div>

<\/div>

F\u00e9vrier 2021<\/h3>
<\/div><\/div><\/div>

R\u00c8GLEMENT D\u2019EX\u00c9CUTION (UE) 2021\/129 DE LA COMMISSION du 3 f\u00e9vrier 2021<\/a> renouvelant l\u2019approbation de la substance active \u00abextrait d\u2019ail\u00bb conform\u00e9ment au r\u00e8glement (CE) no 1107\/2009 du Parlement europ\u00e9en et du Conseil concernant la mise sur le march\u00e9 des produits phytopharmaceutiques, et modifiant l\u2019annexe du r\u00e8glement d\u2019ex\u00e9cution (UE) no 540\/2011 de la Commission<\/p><\/div><\/div>

R\u00c8GLEMENT D\u2019EX\u00c9CUTION (UE) 2021\/134 DE LA COMMISSION du 4 f\u00e9vrier 2021<\/a> renouvelant l\u2019approbation de la substance active \u00e0 faible risque \u00abAkanthomyces muscarius souche Ve6\u00bb (anciennement Lecanicillium muscarium souche Ve6) conform\u00e9ment au r\u00e8glement (CE) no 1107\/2009 du Parlement europ\u00e9en et du Conseil concernant la mise sur le march\u00e9 des produits phytopharmaceutiques, et modifiant l\u2019annexe du r\u00e8glement d\u2019ex\u00e9cution (UE) no 540\/2011 de la Commission.<\/p><\/div><\/div>

R\u00c8GLEMENT D\u2019EX\u00c9CUTION (UE) 2021\/80 DE LA COMMISSION du 27 janvier 2021<\/a> portant non-approbation du dioxyde de carbone en tant que substance de base, conform\u00e9ment au r\u00e8glement (CE) no 1107\/2009 du Parlement europ\u00e9en et du Conseil concernant la mise sur le march\u00e9 des produits phytopharmaceutiques.<\/p><\/div><\/div>

R\u00c8GLEMENT D\u2019EX\u00c9CUTION (UE) 2021\/81 DE LA COMMISSION du 27 janvier 2021 portant approbation de la substance de base \u00abextrait de bulbe d\u2019Allium cepa L.\u00bb conform\u00e9ment au r\u00e8glement (CE) no 1107\/2009 du Parlement europ\u00e9en et du Conseil concernant la mise sur le march\u00e9 des produits phytopharmaceutiques, et modifiant l\u2019annexe du r\u00e8glement d\u2019ex\u00e9cution (UE) no 540\/2011 de la Commission<\/p><\/div><\/div>

R\u00c8GLEMENT D\u2019EX\u00c9CUTION (UE) 2021\/79 DE LA COMMISSION du 27 janvier 2021<\/a> portant non-approbation de la substance active \u00abtopram\u00e9zone\u00bb, conform\u00e9ment au r\u00e8glement (CE) no 1107\/2009 du Parlement europ\u00e9en et du Conseil concernant la mise sur le march\u00e9 des produits phytopharmaceutiques <\/p><\/div><\/div>

R\u00c8GLEMENT D\u2019EX\u00c9CUTION (UE) 2021\/52 DE LA COMMISSION du 22 janvier 2021<\/a> modifiant le r\u00e8glement d\u2019ex\u00e9cution (UE) no 540\/2011 en ce qui concerne la prolongation de la p\u00e9riode d\u2019approbation des substances actives \u00abbenfluraline\u00bb, \u00abdimoxystrobine\u00bb, \u00abfluazinam\u00bb, \u00abflutolanil\u00bb, \u00abm\u00e9coprop-P\u00bb, \u00abm\u00e9piquat\u00bb, \u00abm\u00e9tirame\u00bb, \u00aboxamyl\u00bb et \u00abpyraclostrobine\u00bb<\/p><\/div><\/div>

Typography is the art and technique<\/h2>\n

Typography is the art and technique of arranging type to make written language legible, readable and appealing when displayed. The arrangement of type involves selecting typefaces, point size, line length, line-spacing (leading), letter-spacing (tracking), and adjusting the space within letters pairs (kerning).<\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"

\u00c9volutions  LMRR\u00e9glementaire approbation\/suspensionJuin 2024Mai 2024Commission Regulation (EU) 2024\/1439 of 24 May 2024 amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for fenazaquin, mepiquat and propamocarb […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-1996","page","type-page","status-publish","hentry"],"yoast_head":"\nArchives actualit\u00e9s - Girpa<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.girpa.fr\/index.php\/archives-actualites\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Archives actualit\u00e9s - Girpa\" \/>\n<meta property=\"og:description\" content=\"\u00c9volutions  LMRR\u00e9glementaire approbation\/suspensionJuin 2024Mai 2024Commission Regulation (EU) 2024\/1439 of 24 May 2024 amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for fenazaquin, mepiquat and propamocarb […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.girpa.fr\/index.php\/archives-actualites\/\" \/>\n<meta property=\"og:site_name\" content=\"Girpa\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-12T10:00:13+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"49 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.girpa.fr\\\/index.php\\\/archives-actualites\\\/\",\"url\":\"https:\\\/\\\/www.girpa.fr\\\/index.php\\\/archives-actualites\\\/\",\"name\":\"Archives actualit\u00e9s - Girpa\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.girpa.fr\\\/#website\"},\"datePublished\":\"2020-09-04T10:19:21+00:00\",\"dateModified\":\"2024-06-12T10:00:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.girpa.fr\\\/index.php\\\/archives-actualites\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.girpa.fr\\\/index.php\\\/archives-actualites\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.girpa.fr\\\/index.php\\\/archives-actualites\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.girpa.fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Archives actualit\u00e9s\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.girpa.fr\\\/#website\",\"url\":\"https:\\\/\\\/www.girpa.fr\\\/\",\"name\":\"Girpa\",\"description\":\"Laboratoire d'analyse de r\u00e9sidus de contaminants\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.girpa.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.girpa.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.girpa.fr\\\/#organization\",\"name\":\"Laboratoire Girpa\",\"url\":\"https:\\\/\\\/www.girpa.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.girpa.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.girpa.fr\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/logo-avec-baseline.png\",\"contentUrl\":\"https:\\\/\\\/www.girpa.fr\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/logo-avec-baseline.png\",\"width\":1672,\"height\":454,\"caption\":\"Laboratoire Girpa\"},\"image\":{\"@id\":\"https:\\\/\\\/www.girpa.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Archives actualit\u00e9s - Girpa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.girpa.fr\/index.php\/archives-actualites\/","og_locale":"fr_FR","og_type":"article","og_title":"Archives actualit\u00e9s - Girpa","og_description":"\u00c9volutions  LMRR\u00e9glementaire approbation\/suspensionJuin 2024Mai 2024Commission Regulation (EU) 2024\/1439 of 24 May 2024 amending Annexes II and III to Regulation (EC) No 396\/2005 of the European Parliament and of the Council as regards maximum residue levels for fenazaquin, mepiquat and propamocarb […]","og_url":"https:\/\/www.girpa.fr\/index.php\/archives-actualites\/","og_site_name":"Girpa","article_modified_time":"2024-06-12T10:00:13+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"49 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.girpa.fr\/index.php\/archives-actualites\/","url":"https:\/\/www.girpa.fr\/index.php\/archives-actualites\/","name":"Archives actualit\u00e9s - Girpa","isPartOf":{"@id":"https:\/\/www.girpa.fr\/#website"},"datePublished":"2020-09-04T10:19:21+00:00","dateModified":"2024-06-12T10:00:13+00:00","breadcrumb":{"@id":"https:\/\/www.girpa.fr\/index.php\/archives-actualites\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.girpa.fr\/index.php\/archives-actualites\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.girpa.fr\/index.php\/archives-actualites\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.girpa.fr\/"},{"@type":"ListItem","position":2,"name":"Archives actualit\u00e9s"}]},{"@type":"WebSite","@id":"https:\/\/www.girpa.fr\/#website","url":"https:\/\/www.girpa.fr\/","name":"Girpa","description":"Laboratoire d'analyse de r\u00e9sidus de contaminants","publisher":{"@id":"https:\/\/www.girpa.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.girpa.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.girpa.fr\/#organization","name":"Laboratoire Girpa","url":"https:\/\/www.girpa.fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.girpa.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.girpa.fr\/wp-content\/uploads\/2020\/08\/logo-avec-baseline.png","contentUrl":"https:\/\/www.girpa.fr\/wp-content\/uploads\/2020\/08\/logo-avec-baseline.png","width":1672,"height":454,"caption":"Laboratoire Girpa"},"image":{"@id":"https:\/\/www.girpa.fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.girpa.fr\/index.php\/wp-json\/wp\/v2\/pages\/1996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.girpa.fr\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.girpa.fr\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.girpa.fr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.girpa.fr\/index.php\/wp-json\/wp\/v2\/comments?post=1996"}],"version-history":[{"count":52,"href":"https:\/\/www.girpa.fr\/index.php\/wp-json\/wp\/v2\/pages\/1996\/revisions"}],"predecessor-version":[{"id":3517,"href":"https:\/\/www.girpa.fr\/index.php\/wp-json\/wp\/v2\/pages\/1996\/revisions\/3517"}],"wp:attachment":[{"href":"https:\/\/www.girpa.fr\/index.php\/wp-json\/wp\/v2\/media?parent=1996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}